Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis

Inclusion Criteria

• •Patients with plaque-type psoriasis having \<90%of body surface area involvement, whose disease activity had been stable for the last 1month.
• •Age range 18-65 years of either sex
• •Females who are postmenopausal or tubectomised or have completed their family and are willing to maintain contraception 1 month before, during and 2 years after completion of treatment and negative pregnancy tests within 2 months of starting of treatment.
• •Compliance for scheduled visit.